Affinage

CNTN4

Contactin-4 · UniProt Q8IWV2

Length
1026 aa
Mass
113.5 kDa
Annotated
2026-04-28
27 papers in source corpus 10 papers cited in narrative 10 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

CNTN4 (BIG-2) is a GPI-anchored immunoglobulin superfamily cell adhesion molecule that directs axonal wiring, synapse formation, and synaptic plasticity in the nervous system. Its six Ig-like domains and four fibronectin type III (FnIII) repeats promote neurite outgrowth in vitro (PMID:8586965), and the FnIII domains together with the GPI anchor are required for dendritic spine formation and excitatory synapse assembly in cortical neurons, a function lost in autism-associated CNTN4 variants (PMID:34415325). In vivo, CNTN4 is essential for convergent targeting of olfactory sensory neuron axons to correct glomeruli (PMID:18367085), regulates region-specific surface expression of glutamate and GABAA receptors (PMID:29970989), sustains hippocampal CA1 long-term potentiation and normal fear memory (PMID:33542194), and physically interacts with amyloid precursor protein (APP) to promote neural elongation (PMID:38745463).

Mechanistic history

Synthesis pass · year-by-year structured walk · 7 steps
  1. 1995 High

    Establishing CNTN4 as a neural adhesion molecule with neurite outgrowth–promoting activity answered the fundamental question of whether this new GPI-anchored Ig-superfamily member has direct growth-promoting function for neurons.

    Evidence Molecular cloning with domain analysis and in vitro neurite outgrowth assay using recombinant BIG-2 protein as substrate

    PMID:8586965

    Open questions at the time
    • In vivo role not yet tested
    • No binding partner or receptor identified
    • Which domains mediate neurite outgrowth was unknown
  2. 1997 Medium

    Discovery of a truncated splice variant (BIG-2A) enriched in vomeronasal and olfactory neuroepithelia revealed that alternative splicing could generate a secreted CNTN4 isoform, hinting at region-specific roles in olfactory development.

    Evidence cDNA cloning and in situ hybridization in rat olfactory tissues

    PMID:9221934

    Open questions at the time
    • Functional difference between GPI-anchored and truncated isoform not tested
    • No loss-of-function data in olfactory system
  3. 2008 High

    Knockout mouse studies resolved whether CNTN4 has a non-redundant in vivo guidance role: BIG-2-deficient mice showed ectopic olfactory glomerular innervation, proving CNTN4 is required for axon convergence onto correct glomeruli in the olfactory bulb.

    Evidence BIG-2 knockout mouse with immunohistochemistry, axon tracing, and glomerular mapping across multiple odorant receptors

    PMID:18367085

    Open questions at the time
    • Molecular partners mediating guidance function unknown
    • Whether the secreted splice variant contributes to this phenotype untested
    • Mechanism of receptor-specific glomerular convergence unresolved
  4. 2018 Medium

    Surface biotinylation in Cntn4-knockout brains revealed that CNTN4 controls region-specific surface expression of glutamate (GluA1, GluA2, GluN1) and GABAA receptor subunits, extending its role beyond axon guidance to postsynaptic receptor trafficking.

    Evidence Cell-surface biotinylation and western blotting in cortex, hippocampus, and striatum of Cntn4-KO mice

    PMID:29970989

    Open questions at the time
    • Mechanism by which a GPI-anchored extracellular protein regulates receptor surface levels unknown
    • Whether receptor changes are cell-autonomous or circuit-level effects not distinguished
    • No electrophysiological correlate shown in this study
  5. 2021 High

    Convergent electrophysiological, morphological, and behavioral analyses in Cntn4-KO mice established that CNTN4 sustains hippocampal LTP, proper dendritic arborization and spine morphology, and normal contextual fear memory, linking receptor surface changes to synaptic plasticity deficits.

    Evidence Hippocampal slice electrophysiology (LTP), neuroanatomical spine analysis, and behavioral tests (fear conditioning, Morris water maze) in Cntn4-KO mice

    PMID:33542194

    Open questions at the time
    • Signaling cascade downstream of CNTN4 mediating LTP maintenance unidentified
    • Whether spine and LTP defects are direct or secondary to altered receptor trafficking not resolved
  6. 2021 High

    Domain-deletion and autism-variant analysis in cortical neurons identified the FnIII domains and GPI anchor as the minimal structural requirements for CNTN4-dependent dendritic spine formation, and showed that autism-associated mutations abolish this activity.

    Evidence Overexpression of WT, domain-deleted, and autism-variant CNTN4 in cortical neurons with spine density quantification and electrophysiology

    PMID:34415325

    Open questions at the time
    • Trans-binding partner engaging the FnIII domains during spine formation not identified
    • Structural basis for loss of function in autism variants unknown
    • Whether spine defects drive behavioral phenotypes in vivo not tested
  7. 2024 Medium

    Identification of APP as a direct physical interactor of CNTN4 and demonstration that CNTN4/APP double knockout impairs neural elongation placed the two proteins in a shared neurodevelopmental pathway, providing the first defined trans-signaling partner for CNTN4's growth-promoting function.

    Evidence Mass spectrometry–based interaction proteomics and CNTN4/APP single and double knockout human cells with neural elongation assays

    PMID:38745463

    Open questions at the time
    • Binding interface between CNTN4 and APP not mapped
    • Downstream signaling events triggered by the CNTN4–APP complex uncharacterized
    • In vivo relevance of this interaction for olfactory or hippocampal phenotypes not tested

Open questions

Synthesis pass · forward-looking unresolved questions
  • The signaling cascade through which CNTN4 — a GPI-anchored protein lacking an intracellular domain — transduces extracellular adhesion into intracellular changes in receptor trafficking, dendritic morphogenesis, and synaptic plasticity remains the central unresolved question.
  • No transmembrane co-receptor or lipid-raft signaling intermediate identified
  • Structural basis for CNTN4–APP and CNTN4–phosphatase interactions not determined
  • Cell-type-specific functions across brain regions remain largely uncharacterized

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0098631 cell adhesion mediator activity 3
Localization
GO:0005886 plasma membrane 3
Pathway
R-HSA-1266738 Developmental Biology 3 R-HSA-112316 Neuronal System 2
Partners
APP

Evidence

Reading pass · 10 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1995 BIG-2 (CNTN4) was identified as a GPI-anchored cell adhesion molecule with six Ig-like domains and four fibronectin type III-like repeats; recombinant BIG-2 protein promoted neurite outgrowth when used as a substrate for neurons in vitro, establishing its neurite outgrowth-promoting activity. Molecular cloning, domain analysis, in vitro neurite outgrowth assay with recombinant protein Journal of neurobiology High 8586965
1997 Alternative splicing of BIG-2 (CNTN4) produces a truncated isoform (BIG-2A) lacking the GPI-anchoring domain but retaining six Ig-like domains and a single fibronectin repeat, which is expressed specifically in the vomeronasal and olfactory neuroepithelia. cDNA cloning, in situ hybridization Brain research. Molecular brain research Medium 9221934
2002 A novel splice variant of human CNTN4 (CNTN4A) encodes a protein with an N-terminal signal peptide, two FNIII-like domains, and a GPI-anchoring domain, and is predominantly expressed in brain. cDNA library screening, sequencing, expression analysis Journal of human genetics Medium 12202991
2008 BIG-2/CNTN4 functions as an axon guidance molecule required for the convergence of olfactory sensory neuron axons onto correct glomeruli in the olfactory bulb; in BIG-2-deficient mice, neurons expressing a given odorant receptor innervate multiple ectopic glomeruli, disrupting the odor map. BIG-2 knockout mouse model, immunohistochemistry, axon tracing, olfactory glomerular mapping Neuron High 18367085
2011 Computational steered molecular dynamics analysis of all six IgC2 domains of human CNTN4 revealed that IgC2 domains 2 and 3—critical for interactions with tyrosine phosphatases—are mechanically vulnerable even to weak stretching forces, suggesting tension can modulate CNTN4 binding activity. Steered molecular dynamics simulation with CHARMM force field Journal of molecular modeling Low 21445711
2018 In Cntn4-/- mice, cell surface levels of glutamate receptor subunits (GluA1, GluA2, GluN1) are reduced in cortex and hippocampus but increased in striatum, and GABAA receptor α1 surface expression is downregulated in multiple brain regions, indicating CNTN4 regulates region-specific glutamate and GABA receptor surface expression. Biotinylation assay, western blotting, Cntn4 knockout mouse Frontiers in molecular neuroscience Medium 29970989
2021 Cntn4 knockout mice show reduced LTP in hippocampal CA1, abnormal dendritic arborization and spine morphology of CA1 neurons, and enhanced contextual fear conditioning in a gene-dose-dependent manner, establishing CNTN4's role in hippocampal synaptic plasticity and fear memory. Cntn4 KO mouse model, electrophysiology (LTP in hippocampal slices), neuroanatomical analysis, behavioral testing (fear conditioning, Morris water maze, novel object recognition) Translational psychiatry High 33542194
2021 CNTN4 promotes dendritic spine formation in cortical neurons through a mechanism dependent on its FnIII domains and GPI anchor; truncated proteins lacking the signal peptide, FnIII domains, or GPI domain fail to regulate spine density, and autism-associated variants of CNTN4 lack this ability, leading to reduced excitatory synapses and decreased neural activity. Cntn4 disruption in cortical neurons, dendritic spine counting, electrophysiology, domain deletion constructs, autism-variant overexpression Human molecular genetics High 34415325
2022 miR-148a-3p directly targets the 3'UTR of CNTN4 (validated by dual-luciferase reporter assay); upregulation of miR-148a-3p suppresses CNTN4 expression and reduces oxLDL-induced macrophage apoptosis and IL-6/TNF-α production. Dual-luciferase reporter assay, qRT-PCR, flow cytometry, ELISA in THP-1 macrophages Annals of translational medicine Medium 36544657
2024 CNTN4 physically interacts with amyloid precursor protein (APP) as identified by mass spectrometry; knockout of CNTN4 and/or APP in human cells impairs neural elongation, and the CNTN4-APP interaction is required for normal nerve outgrowth, placing CNTN4 upstream of APP in a neurodevelopmental pathway. Mass spectrometry proteomics, CNTN4/APP knockout human cells, neural elongation assay Open biology Medium 38745463

Source papers

Stage 0 corpus · 27 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
1995 Overlapping and differential expression of BIG-2, BIG-1, TAG-1, and F3: four members of an axon-associated cell adhesion molecule subgroup of the immunoglobulin superfamily. Journal of neurobiology 141 8586965
2004 Disruption of contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome. American journal of human genetics 131 15106122
2008 BIG-2 mediates olfactory axon convergence to target glomeruli. Neuron 130 18367085
2018 Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: Analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials. Cancer 58 30335191
2006 FISH and array-CGH analysis of a complex chromosome 3 aberration suggests that loss of CNTN4 and CRBN contributes to mental retardation in 3pter deletions. American journal of medical genetics. Part A 58 17036314
2014 Central pathology laboratory review of HER2 and ER in early breast cancer: an ALTTO trial [BIG 2-06/NCCTG N063D (Alliance)] ring study. Breast cancer research and treatment 55 24395109
2019 Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trial. Breast cancer research and treatment 37 31134488
2021 Cntn4, a risk gene for neuropsychiatric disorders, modulates hippocampal synaptic plasticity and behavior. Translational psychiatry 35 33542194
2018 Heterogeneity of Cell Surface Glutamate and GABA Receptor Expression in Shank and CNTN4 Autism Mouse Models. Frontiers in molecular neuroscience 30 29970989
2021 Body Mass Index and Weight Change in Patients With HER2-Positive Early Breast Cancer: Exploratory Analysis of the ALTTO BIG 2-06 Trial. Journal of the National Comprehensive Cancer Network : JNCCN 22 33401235
2002 A novel splice variant of the cell adhesion molecule contactin 4 ( CNTN4) is mainly expressed in human brain. Journal of human genetics 21 12202991
2003 Cloning and characterization of the human neural cell adhesion molecule, CNTN4 (alias BIG-2). Cytogenetic and genome research 20 14571131
2021 Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D). European journal of cancer (Oxford, England : 1990) 17 33765513
2017 p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial. International journal of oncology 16 29207087
2016 Limited impact of Cntn4 mutation on autism-related traits in developing and adult C57BL/6J mice. Journal of neurodevelopmental disorders 16 26958094
2016 GWAS and transcriptional analysis prioritize ITPR1 and CNTN4 for a serum uric acid 3p26 QTL in Mexican Americans. BMC genomics 16 27039371
2015 Combined Whole Methylome and Genomewide Association Study Implicates CNTN4 in Alcohol Use. Alcoholism, clinical and experimental research 16 26146898
2019 Intragenic CNTN4 copy number variants associated with a spectrum of neurobehavioral phenotypes. European journal of medical genetics 13 31422286
2022 MiR-148a-3p attenuates apoptosis and inflammation by targeting CNTN4 in atherosclerosis. Annals of translational medicine 11 36544657
1997 A novel splice variant of the cell adhesion molecule BIG-2 is expressed in the olfactory and vomeronasal neuroepithelia. Brain research. Molecular brain research 11 9221934
2007 The CNTN4 c.4256C>T mutation is rare in Japanese with inherited spinocerebellar ataxia. Journal of the neurological sciences 7 17915252
2021 The autism risk gene CNTN4 modulates dendritic spine formation. Human molecular genetics 6 34415325
2011 Nanomechanics of Ig-like domains of human contactin (BIG-2). Journal of molecular modeling 6 21445711
2024 CNTN4 modulates neural elongation through interplay with APP. Open biology 5 38745463
2022 Effect of the Minor C Allele of CNTN4 rs2619566 on Medial Hypothalamic Connectivity in Early-Stage Patients of Chinese Han Ancestry with Sporadic Amyotrophic Lateral Sclerosis. Neuropsychiatric disease and treatment 3 35250268
2024 Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)]. ESMO open 1 39418883
2025 Cntn4 Gene Deficiency Promotes Autism-Like Phenotypes Associated with Gut Microbiota Perturbations and Gut-Brain Axis Metabolomic Alterations in Mice. Molecular neurobiology 0 41326871